BGLC - CIK 0001737523
The table below shows BioNexus Gene Lab Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $79.86K | $1.52M | $1.85M | - | - | - |
| Inventory | $667.15K | $1.01M | $1.22M | $1.18M | $1.39M | $1.03M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $5.20M |
| $5.63M |
| $6.38M |
| $6.54M |
| $7.04M |
| $7.84M |
| Property, plant & equipment | $1.58M | $1.57M | $1.59M | $1.52M | $1.73M | $1.35M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $9.04M | $7.62M | $9.42M | $9.48M | $11.00M | $11.14M |
| Accounts payable | - | - | - | $1.18M | $1.03M | $954.78K |
| Total current liabilities | $796.47K | $678.02K | $1.76M | $1.56M | $1.41M | $1.40M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $946.88K | $804.97K | $1.90M | $1.71M | $1.61M | $1.59M |
| Retained earnings | -$6.97M | -$5.39M | -$4.68M | -$4.07M | -$3.09M | -$1.75M |
| Total equity | $8.09M | $6.82M | $7.52M | $7.77M | $9.39M | $9.55M |